Areas of inquiry include closer mapping of the relationship of out- comes to ambulatory and home BP measurements, so that definitions of hypertension and hypertension severity based on Clinician follow-up, monitoring, and care coordination Follow-up visits Sections 8.1.3, Team-based care Section 12.2 Electronic health record Section 12.3.1 Health information technology tools for remote and self-monitoring Socioeconomic and cultural factors Health literacy Section 13.1.3 Access to health insurance and medication assistance plans Social services Section 13.1.3 Community services Section 13.1.3 BP indicates blood pressure. Table 22. Continued Plan of Care Associated Section(s) of Guideline and Other Reference(s) Table 23. BP Thresholds for and Goals of Pharmacological Therapy in Patients With Hypertension According to Clinical Conditions Clinical Condition(s) BP Threshold, mm Hg BP Goal, mm Hg General Clinical CVD or 10-year ASCVD No clinical CVD and 10-year ASCVD risk <10% Older persons ( 65 years of age; noninstitutionalized, ambulatory, community-living adults) Specific comorbidities Chronic kidney disease 130/80 <130/80 Chronic kidney disease after renal transplantation Stable ischemic heart disease 130/80 <130/80 Secondary stroke prevention 140/90 <130/80 Peripheral artery disease 130/80 <130/80 ASCVD indicates atherosclerotic cardiovascular disease; BP, blood pressure; CVD, cardiovascular disease; and SBP, systolic blood pressure. these measures can be developed, including the importance of masked hypertension, white coat hypertension, and nocturnal hypertension. Reproducibility of ambulatory and home BPs must be studied, and cohorts should include a broader range of ethnicities. Trials with entry criteria and treatment goals based on ambulatory or home BP measures should be con- ducted, including studies of masked and white coat hyperten- sion. The practicality and cost of incorporating ABPM into EHR and routine care should be assessed. The existence of these techniques should not hamper efforts to investigate ways to improve accuracy in the measurement of clinic BP. 